Targeting EGFR signalling pathway in triple negative breast cancer

<p>Epidermal growth factor receptor (EGFR) is frequently overexpressed in the majority of triple negative breast cancer patients (TNBC). However, the molecular determinants behind their limited response to EGFR-targeted therapies are poorly understood. Here, both the acute and chronic response...

Deskribapen osoa

Xehetasun bibliografikoak
Egile nagusia: Albukhari, A
Beste egile batzuk: Ahmed, A
Formatua: Thesis
Hizkuntza:English
Argitaratua: 2014
Gaiak:

Antzeko izenburuak